Valeos Pharma A/S
CVR 39696614 · Public limited company (A/S) · Active · Medium risk
Valeos Pharma A/S is a Public limited company (A/S), founded on , based in Holeby. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 7 annual reports have been published, of which 6 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -6.7m and a net result of DKK -13.5m.
Bankruptcy risk for Valeos Pharma A/S
1.4 × the average (1.41%) · higher risk than 84% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39696614
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (8 years)
- Address
- Østervej 2
4960 Holeby - Municipality
- Lolland
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 803k
- Auditor
- BDO Statsautoriseret Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 6 of 7 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -12.7% |
| Current ratio | 34% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 19 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 976k | DKK -3.8m |
| Net profit | DKK -13.5m | DKK -16.9m |
| Equity | DKK -6.7m | DKK 6.8m |
| Total assets | DKK 52.8m | DKK 58.1m |
| Short-term debt | DKK 26.9m | DKK 20.5m |
| Avg. employees | 19 | 19 |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · BDO.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 194 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 179 | ||
| 1 Jan 2023 – 31 Dec 2023 | 185 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 187 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 201 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 189 | Late | |
| 3 Jul 2018 – 31 Dec 2019 | 275 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Frederik Andreasen | ||
| Board | Michael Halborg-Bendtsen | Current | |
| Board | Peter Frederik Andreasen | Current | |
| Board | Kristian Schrøder Hart-Hansen | Current | |
| Board | Glenn Steven Nielsen | Current | |
| Board | Glenn Steven Nielsen | ||
| Board | Totti Hannu Miikael Vuosio | ||
| Board | Kristian Schrøder Hart-Hansen | ||
| Board | Michael Andreasen | ||
| Board | Kristian Schrøder Hart-Hansen | ||
| Board | Glenn Steven Nielsen | ||
| Board | Henrik Kristian Moltke | ||
| Owner (15%) | A. Rosen Holding ApS | Current | |
| Owner (50%) | MSG Capital APS | Current | |
| Owner (10%) | Kleingut ApS | Current | |
| Owner (10%) | Peter Frederik Andreasen | ||
| Owner (20%) | Totti Hannu Miikael Vuosio | ||
| Owner (50%) | MSG Capital APS | ||
| Owner (10%) | A. Rosen Holding ApS | ||
| Owner (10%) | Kleingut ApS | ||
| Owner (20%) | Novosato Holding ApS | ||
| Owner (10%) | A. Rosen Holding ApS | ||
| Owner (5%) | Henriksholm 2018 ApS | ||
| Owner (50%) | MSG Capital APS | ||
| Owner (15%) | Kleingut ApS | ||
| Auditor | BDO Statsautoriseret Revisionspartnerselskab | Current | |
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Auditor | BDO Holding VII, statsautoriseret revisionsaktieselskab | ||
| Founder | Peter Frederik Andreasen | Current |
The CEOs' other companies
Peter Frederik Andreasen – 5 other companies, of which 1 bankrupt
- MIMICO A/S Bankrupt 2 Jul 2007
- FRESOMA TRADING& INVEST IVS Compulsorily dissolved
- Kleingut ApS Active
- PALÆO TORVEHALLERNE ApS Active
- seo360 ApS Active
Address history (0 moves)
| Østervej 2, 4960 Holeby |
Former names
| Valeos Pharma A/S | – now |
| Valeos A/S | – |
| Valeos ApS | – |
| Valeos IVS | – |
Other companies at the same address
- A/H STEEL-DESIGN ApS Bankrupt
- KRYDSVIKAR ApS Bankrupt
- PMU.IVS.DK Bankrupt
- DB-Service ApS Active
- ERHVERVSPARK LOLLAND A/S Active
- FEMERN BELT SERVICES A/S Opløst
- GTA Corporation ApS Active
- GTA Market Development ApS Active
- HOLEBY HOLDING A/S Active
- HOLEBY INDUSTRIGRUNDE A/S Active
- Havdrup Minibusser ApS Active
- ISODAN ApS Active
- Isodan Engineering ApS Active
- KERATON ApS Active
- Kleingut ApS Active
- Kokkehjælp ApS Active
- LF TECHNICAL CONTRACTORS ApS Compulsorily dissolved
- Lindhard Gruppen ApS Compulsorily dissolved
- PIER 1 RØDBY HAVN ApS Opløst
Questions and answers about Valeos Pharma A/S
Has Valeos Pharma A/S gone bankrupt?
No, Valeos Pharma A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Valeos Pharma A/S?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the auditor of Valeos Pharma A/S?
Valeos Pharma A/S most recently used BDO Statsautoriseret Revisionspartnerselskab.
When was Valeos Pharma A/S founded?
Valeos Pharma A/S was founded on 3 July 2018.
What is the equity of Valeos Pharma A/S?
Equity was DKK -6.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.